Quoin Pharmaceuticals Files 8-K on Financials
Ticker: QNRX · Form: 8-K · Filed: May 14, 2025 · CIK: 1671502
| Field | Detail |
|---|---|
| Company | Quoin Pharmaceuticals, Ltd. (QNRX) |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
Quoin Pharma dropped an 8-K on May 13th detailing their financial condition.
AI Summary
Quoin Pharmaceuticals Ltd. filed an 8-K on May 14, 2025, reporting on its results of operations and financial condition as of May 13, 2025. The company, formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd., is incorporated in Israel and has its principal executive offices in Ashburn, VA.
Why It Matters
This filing provides an update on Quoin Pharmaceuticals' financial status and operational results, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing with no immediate new material events or significant financial changes indicated.
Key Players & Entities
- Quoin Pharmaceuticals Ltd. (company) — Filer
- Cellect Biotechnology Ltd. (company) — Former company name
- Cellect Biomed Ltd. (company) — Former company name
- May 13, 2025 (date) — Date of earliest event reported
- May 14, 2025 (date) — Filing date
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Quoin Pharmaceuticals Ltd.'s Results of Operations and Financial Condition as of May 13, 2025.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on May 14, 2025.
What were Quoin Pharmaceuticals Ltd.'s previous names?
Quoin Pharmaceuticals Ltd. was formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd.
In which jurisdiction is Quoin Pharmaceuticals Ltd. incorporated?
Quoin Pharmaceuticals Ltd. is incorporated in the State of Israel.
What is the address of Quoin Pharmaceuticals Ltd.'s Principal Executive Offices?
The address of Quoin Pharmaceuticals Ltd.'s Principal Executive Offices is 42127 Pleasant Forest Court, Ashburn, VA 20148-7349.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Quoin Pharmaceuticals, Ltd. (QNRX).